CoChat

Measures of depression and depressive symptoms: The Beck Depression Inventory (BDI), Center for Epidemiological Studies-Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Primary Care Evaluation of Mental Disorders-Mood Module (PRIME-MD)

Smarr, Karen L. · 2003 · Arthritis & Rheumatism
Cited by 54

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

To measure depression symptoms and severity in persons age 13 and older. Based on clinical observations and patient description, the BDI contains items that reflect the cognitive, affective, somatic, and vegetative symptoms of depression (1,2). Aaron T. Beck, PhD, Center for Cognitive Therapy, Philadelphia, PA. The revised BDI (BDI-IA) (3), replaced the original version (2). The BDI-IA is similar to the original, except timeframe extends "over the past week, including today" and some items were reworded to avoid double negative statements. The BDI-II contains substantial revision of the original and revised BDI so that the assessment of symptoms corresponds to the DSM-IV criteria (4). BDI-II timeframe extends for 2 weeks to correspond with the DSM-IV criteria for major depressive disorder. BDI FastScreen for Medical Patients (formerly known as BDI-Primary Care [BDI-PC]) contains 7 cognitive and affective items from the BDI-II to assess depression in individuals with biomedical or substance abuse problems (5). The BDI FastScreen excludes the somatic items from BDI-II. The timeframe on the BDI FastScreen is the same as BDI-II. The BDI has been translated into several languages, including Spanish, Chinese, Dutch, Finnish, French (Canadian), German, Korean, Polish, Swedish, and Turkish (6). There are 21 items in the BDI-IA and BDI-II; and 7-items in the BDI FastScreen. None typically reported. The BDI-IA manual discusses the cognitive-affective (Items 1–13) and the somatic-performance (Items 14–21) subscales that discriminate between psychiatric, medical, and normal samples (2). Factors analysis of the BDI-II revealed two intercorrelated factors, somatic-affective and cognitive dimensions (3). BDI-IA: developed and validated using psychiatric and normal populations. Beck and colleagues (3) studied outpatient samples that included persons with severe psychiatric diagnoses, depressive disorders, substance abuse, and college students. BDI-II validated using college students, adult psychiatric outpatients, and adolescent psychiatric outpatients (4). BDI-FastScreen validated using general medical inpatients referred for psychiatric consultation and outpatients seen by family practice, pediatrics, and internal medicine (5). Since being revised in 1972, the BDI has been widely accepted and used in psychology and psychiatry for assessing the intensity of depression in psychiatric and normal populations. Studies have been conducted in a variety of settings using medical populations (e.g., Parkinson's disease, human immunodeficiency virus, oncology), persons with disabilities, (e.g., arthritis, spinal cord injury, amputation), veterans, students, older adults, adolescents, and many populations with psychiatric diagnoses (e.g., eating disorders, addictions, anxiety disorders). Participation restriction. Paper and pencil self-report in group or individual format; self or oral administration. Minimal training required for paraprofessionals or professionals to administer. A clinician needs to interpret the revised BDI score by paying particular attention to items endorsing self harm or feelings of helplessness, such as suicide ideation (item 9) and pessimism/hopelessness (item 2). Self-administration: 5-10 minutes; Oral administration: 15 minutes. Pencil or pen to indicate response. Contact The Psychological Corporation to purchase the BDI, BDI-II, or the BDI FastScreen for Medical Patients manuals and instrument. Computer software is available from Psychological Corporation for on-screen administration, for use with paper and pencil administration, or for input of data from a desktop scanner. The computer program may be used to administer a single questionnaire or to integrate the results of sequential administrations. The Psychological Corporation, 555 Academic Court, San Antonio, TX 78204; Website: www.psychcorp.com. Items may be seen in McDowell and Newell (7). 4-point scale indicates degree of severity; items are rated from 0 (not at all) to 3 (extreme form of each symptom). BDI: 0–63; BDI-II: 0–63; BDI FastScreen: 0–21. No arbitrary cut-off score for all purposes to classify different degrees of depression.The following guidelines have been suggested to interpret the revised BDI (the BDI-IA) (3). With the normal population, a BDI-IA score of ≥15 may indicate possible depression and warrants an additional clinical evaluation as confirmation. Minimal range 0–9; Mild depression 10–16; Moderate depression 17–29; Severe depression 30–63. The following guidelines have been suggested to interpret the BDI-II (4), Minimal range 0–13; Mild depression 14–19; Moderate depression 20–28; Severe depression 29–63. The following guidelines have been suggested to interpret the BDI FastScreen for Medical Patients (5). Minimal 0–3; Mild depression 4–8; Moderate depression 9–12; Severe depression 13–21. Sum the severity ratings of each depression item. Use the highest response when an item has more than one severity rating. Special instruc

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.11410

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 54

Metadata

Authors
Smarr, K. L.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2003-10-15
Volume
49
Issue
S5
Pages
S134-S146
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2038444828
Cited by
54
References
1
FWCI
0.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.